LIBERT RAMOS: Open Payments
NPI 1326496555 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 19 payments from 10 companies in 2025. Trend: 2023 $6,156 · 2024 $775 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $189 |
| Sumitomo Pharma America, Inc. | 5 | $104 |
| 180 Medical, Inc. | 2 | $89 |
| Teleflex LLC | 2 | $64 |
| Verity Pharmaceuticals Inc. | 2 | $47 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $45 |
| Boston Scientific Corporation | 1 | $32 |
| Endo USA, Inc. | 1 | $27 |
| TOLMAR, INC. | 1 | $22 |
| COLOPLAST CORP | 1 | $19 |
Products named: RYBREVANT, GEMTESA, DEKNATEL, CURE CATHETER, Tlando, PYLARIFY, AdVance XP, GENTLECATH.
Industry payments across FL — which companies pay providers there.
